News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
843,675 Results
Type
Article (86285)
Company Profile (654)
Press Release (756736)
Multimedia
Podcasts (126)
Webinars (13)
Section
Business (232575)
Career Advice (4125)
Deals (39713)
Drug Delivery (129)
Drug Development (90917)
Employer Resources (198)
FDA (18065)
Job Trends (17324)
News (396224)
Policy (39716)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (89)
Alliances (56787)
ALS (96)
Alzheimer's disease (1485)
Antibody-drug conjugate (ADC) (138)
Approvals (18040)
Artificial intelligence (282)
Autoimmune disease (26)
Automation (15)
Bankruptcy (403)
Best Places to Work (12617)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (448)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (279)
Cancer (2216)
Cardiovascular disease (193)
Career advice (3530)
Career pathing (33)
CAR-T (161)
Cell therapy (452)
Cervical cancer (20)
Clinical research (73176)
Collaboration (863)
Compensation (524)
Complete response letters (28)
COVID-19 (2854)
CRISPR (45)
C-suite (241)
Cystic fibrosis (106)
Data (2101)
Decentralized trials (2)
Denatured (44)
Depression (47)
Diabetes (266)
Diagnostics (6888)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (128)
Drug pricing (117)
Drug shortages (29)
Duchenne muscular dystrophy (98)
Earnings (96272)
Editorial (41)
Employer branding (25)
Employer resources (167)
Events (129339)
Executive appointments (723)
FDA (19293)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (767)
Gene editing (115)
Generative AI (27)
Gene therapy (334)
GLP-1 (818)
Government (5140)
Grass and pollen (5)
Guidances (51)
Healthcare (20862)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (134)
Indications (27)
Infectious disease (3002)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (94)
Interviews (812)
IPO (17798)
IRA (48)
Job creations (5185)
Job search strategy (2861)
Kidney cancer (10)
Labor market (40)
Layoffs (544)
Leadership (21)
Legal (10097)
Liver cancer (78)
Lung cancer (319)
Lymphoma (143)
Machine learning (5)
Management (65)
Manufacturing (317)
MASH (69)
Medical device (14574)
Medtech (14579)
Mergers & acquisitions (22407)
Metabolic disorders (729)
Multiple sclerosis (80)
NASH (23)
Neurodegenerative disease (104)
Neuropsychiatric disorders (30)
Neuroscience (2042)
NextGen: Class of 2025 (7668)
Non-profit (5075)
Northern California (2586)
Now hiring (39)
Obesity (395)
Opinion (271)
Ovarian cancer (76)
Pain (89)
Pancreatic cancer (83)
Parkinson's disease (154)
Partnered (23)
Patents (235)
Patient recruitment (103)
Peanut (51)
People (65150)
Pharmaceutical (135)
Pharmacy benefit managers (21)
Phase I (22584)
Phase II (31772)
Phase III (23947)
Pipeline (1154)
Policy (157)
Postmarket research (3551)
Preclinical (10144)
Press Release (72)
Prostate cancer (102)
Psychedelics (37)
Radiopharmaceuticals (268)
Rare diseases (410)
Real estate (7391)
Recruiting (75)
Regulatory (26663)
Reports (57)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (75)
Series A (136)
Series B (87)
Service/supplier (27)
Sickle cell disease (58)
Southern California (2238)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4287)
State (2)
Stomach cancer (14)
Supply chain (67)
Tariffs (29)
The Weekly (80)
United States (23294)
Vaccines (780)
Venture capitalists (41)
Weight loss (281)
Women's health (39)
Worklife (19)
Date
Last 7 days (500)
Last 30 days (2278)
Last 365 days (34878)
2025 (9738)
2024 (37615)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (59)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (50015)
Australia (8819)
California (6025)
Canada (1974)
China (521)
Colorado (267)
Connecticut (275)
Delaware (142)
Europe (114614)
Florida (884)
Georgia (211)
Hawaii (1)
Idaho (64)
Illinois (584)
India (29)
Indiana (316)
Iowa (10)
Japan (153)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (67)
Maryland (922)
Massachusetts (4644)
Michigan (228)
Minnesota (403)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (26)
Nevada (62)
New Hampshire (66)
New Jersey (1730)
New Mexico (30)
New York (1710)
North Carolina (1084)
North Dakota (8)
Northern California (2586)
Ohio (204)
Oklahoma (15)
Oregon (45)
Pennsylvania (1342)
Puerto Rico (12)
Rhode Island (32)
South America (1652)
South Carolina (20)
South Dakota (1)
Southern California (2238)
Tennessee (101)
Texas (902)
Utah (179)
Virginia (149)
Washington D.C. (65)
Washington State (574)
West Virginia (3)
Wisconsin (55)
843,675 Results for "bio rad laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
April 15, 2025
·
1 min read
Press Releases
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
February 14, 2025
·
4 min read
Business
Bio-Rad Reports First-Quarter 2024 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
22 min read
Business
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
Bio-Rad Laboratories, Inc. today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024.
May 30, 2024
·
4 min read
Press Releases
Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
February 14, 2025
·
19 min read
Business
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Laboratories, Inc. today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024.
April 26, 2024
·
2 min read
Business
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Bio-Rad Laboratories, Inc. will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market.
April 18, 2024
·
1 min read
Business
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024.
April 10, 2024
·
1 min read
Biotech Bay
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
Bio-Rad Laboratories, Inc. today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 10:30 AM Eastern Time (7:30 AM Pacific Time).
May 23, 2024
·
1 min read
Press Releases
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
January 27, 2025
·
1 min read
1 of 84,368
Next
